CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx gross margin
Gross margin is gross profit as a percentage of revenue.
CannaPharmaRx's gross margin for the twelve months ending Sep 30, 2026 was -130.7%. For fiscal 2025 it was -153.1%, against -357.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -153.1% | +204.8 |
| FY2024 | Dec 31, 2024 | -357.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -201.7% | −144.8 |
| Q2 FY2026 | Jun 30, 2026 | -50.1% | +218.1 |
| Q1 FY2026 | Mar 31, 2026 | -65.3% | +84.6 |
| Q4 FY2025 | Dec 31, 2025 | -517.2% | −166.5 |
| Q3 FY2025 | Sep 30, 2025 | -56.9% | +57.2 |
| Q2 FY2025 | Jun 30, 2025 | -268.2% | +1424.6 |
| Q1 FY2025 | Mar 31, 2025 | -149.9% | – |
| Q4 FY2024 | Dec 31, 2024 | -350.7% | – |
| Q3 FY2024 | Sep 30, 2024 | -114.1% | – |
| Q1 FY2024 | Mar 31, 2024 | -1692.8% | – |
See a number that looks wrong?